- Consumer trust intact as McNeil brands like Tylenol return back to shelf
- J&J's return to market of several iconic OTC brands a success
- Energizer completes acquisition of feminine hygiene business from J&J Family of Consumer Cos.
- ROUNDTABLE: Pharmacy’s future in sync with technology
- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
NEW YORK — Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities."
The brands managed by the unit include intimacy health KY and women's personal care brands, o.b. tampons and Stayfree and Carefree pads.
Recent brands sold by J&J have included e.p.t. pregnancy tests, Monistat and Rolaids.
The Wall Street Journal projected that more consumer brands considered non-core to J&J's growth strategies will be jettisoned as well, potentially including Band-Aid, Listerine, Neutrogena and even Tylenol.
But the company will not be exiting the OTC arena altogether, the report suggested, citing J&J's ongoing interest in eyecare company Bausch & Lomb.
Find us on Facebook for even more insight, analysis and the latest in drug store news.